BOBBI ANDERSON: Open Payments
NPI 1699339648 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 39 payments from 10 companies in 2025. Trend: 2023 $997 · 2024 $731 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $187 |
| Phathom Pharmaceuticals, Inc. | 3 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $145 |
| Lilly USA, LLC | 10 | $119 |
| ABBVIE INC. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VOQUEZNA, AIRSUPRA, Wegovy, MOUNJARO, Ozempic, QULIPTA, JARDIANCE, LEQVIO.
Industry payments across KY — which companies pay providers there.
